By Chol D. Johnson
The Brilliant Pharmaceutical Company (BPC) has officially opened in Juba, South Sudan, bringing health services closer to the public.
Established on 4th Jury 2024, BPC became fully operational over the weekend, a rescue plan in the South Sudan pharmaceutical sector.
With a focus on all forms of supply of human medicines, the BPC remains a choice for clinics and health centers in need of quality products.
Located in Muniki, the company deals in quality medicines in different categories, such as anti-malaria (Artebril injection, tablet, and dry syrup) and antibiotic products (Azibril tablet, Metrobril tablet, Cefbril injection, Cefbril tablet, and Ciprobril tablet), at affordable prices.
However, during the official opening on Saturday, the participants described the company as a national company inclusively established by young and energetic youth comprising entrepreneurs and pharmaceutical specialists.
The event attracted government officials, health experts, top officials of pharmaceutical companies, the Chamber of Commerce, the food and drug authority, and doctors from the South Sudan Medical Council, among others.
Addressing the participants during the occasion, Nagwa Juma Mursal, the Minister of Health in Central Equatoria State (CES), who was the patron of the day, expressed applause for the young South Sudanese for coming up with a company.
“I’m very happy to see the group of young women, our sons and daughters, who are happy to come out together to create employment; you will promote our young generation,” Juma said.
She expressed the state government’s role in ensuring that quality medicine is supplied to the South Sudan market.
“We are in continuous monitoring of the medicines after they enter the market to help and coordinate with the other authorities to detect, assess, and prevent the adverse effects of that product and important environmental and safety standards,” she expressed.
She urged the public to trust and support Brilliant Pharmaceutical Company (BPC), adding that it is meant to bring quality medicines near the public.
Juma called for the protection of the public health by ensuring that the drug is safe and effective.
As she launched or opened the BPC, Juma urged the company to ensure that the medicine reaches a larger population.
“I wish you the brilliance of your company, now that the company is officially launched,” she declared.
Meanwhile, the Director General for Quality Control at the Drug and Food Control Authority, Dr. Rita Gabriel Tulba, welcomed the investment in human medicines, citing that it remains vital in the society.
“We welcome this investment as DFCA. Let us remind ourselves that this partnership has to start strong, and it has to be ethical and transparent in the regulatory authority.” Gabriel said,
She called for a transparent framework, citing that they need to work hand in hand with Brilliant Pharmaceutical.
Gabriel expressed that the establishment of a pharmaceutical company here in South Sudan is not only a business milestone, but also a public health achievement.
She added that it represents a step toward national self-reliance in the supply of essential medicines as the country continues to experience shortages of essential medicines.
“The national regulatory authority body DFCA will play a good role; our mandate is to protect the health of our citizens,” she said.
The Acting Chief Executive Officer (CEO) of Brilliant Pharmaceutical Company, Dr. Gimalla Patrice, reaffirmed the company’s commitment to providing quality medicine to the public.
He added that the BPC team will continue to work collaboratively and diligently with all stakeholders to ensure easy access to quality health services for all.
Patrice revealed that, being officially launched, the company will continue to supply quality medicines to the market.
He expressed that the team that established the company remains committed and prioritizes the health of South Sudanese.
“This brilliant pharmaceutical company was established by a young South Sudanese entrepreneur, who put the health of South Sudanese as one of his priorities,” he said.
He revealed that the company has future plans of venturing into the manufacturing of pharmaceutical products in South Sudan.
“We will ensure to translate the vision of the company into indigenous manufacturing of pharmaceutical products,” he added.
“In Brilliant, we are proud to have had our product tested for quality, and we have all successfully passed, as it was just presented,” he added.
Patrice added that it is one of the steps they profoundly took to ensure quality medicines and other pharmaceutical products.